Skip to main content

Table 3 Serum lipid levels of pregnant women with SCH who did or did not receive treatment

From: Significance of levothyroxine treatment on serum lipid in pregnant women with subclinical hypothyroidism

Serum lipid levels

 

SCH non-intervention Group (n = 103)

SCH treatment Group (n = 319)

TC (mmol/L)

first trimester of pregnancy

4.37(0.77)

4.29(3.80–4.81)

third trimester of pregnancy

6.61(1.29)

6.42(5.62–7.05)

TG (mmol/L)

first trimester of pregnancy

1.06(0.85–1.47)

1.07(0.81–1.44)

third trimester of pregnancy

2.99(2.49–3.74)

2.81(2.32–3.52)

LDL-C(mmol/L)

first trimester of pregnancy

2.28(0.61)

2.20(1.77–2.61)

third trimester of pregnancy

3.64(1.10)

3.41(2.70–4.09)

HDL-C(mmol/L)

first trimester of pregnancy

1.55(1.34–1.77)

1.55(1.35–1.75)

third trimester of pregnancy

1.80(1.61–1.97)

1.84(0.36)

  1. TC Total cholesterol, TG Triglycerides, LDL-C Low-density lipid cholesterol, HDL-C High-density lipid cholesterol
  2. continuous variables were presented as mean (standard deviation [SD]) or median (interquartile range)